3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering

Traditional drug manufacturing methods are limited in their ability to produce customized dosage forms. Recent advances in 3D printing have introduced new possibilities for tailoring medications to individual patient needs. Prior research has shown that 3D printing can enable precise control over drug release and dosage. However, the application of selective laser sintering (SLS) for personalized drug products remains underexplored. This gap motivated the investigation of SLS as a method for producing carvedilol tablets with specific strengths. No prior work had resolved how laser parameters influence drug release and tablet properties. The use of CO2 lasers in pharmaceutical printing is a novel area requiring further study. This study aimed to explore the feasibility of SLS for personalized drug formulations. The potential of SLS to meet patient-specific requirements was a key focus.

The goal was to assess the viability of selective laser sintering (SLS) for creating personalized carvedilol tablets of varying strengths. Carvedilol is a drug used in cardiovascular conditions, and its dosage often needs adjustment based on patient response. The study aimed to determine how laser parameters affect tablet properties like hardness and drug release. Researchers wanted to evaluate the role of laser intensity in the printing process. The motivation was to develop a method that allows for tailored drug delivery. This approach could improve treatment outcomes by matching dosages to individual needs. The study also sought to understand how formulation ratios influence tablet characteristics. The findings could support the adoption of SLS in pharmaceutical manufacturing.

The study used selective laser sintering (SLS) with a CO2 laser to fabricate carvedilol tablets. Blends of carvedilol and Kollidon VA64 were prepared in different ratios. The laser intensity was adjusted to assess its impact on tablet properties. Tablets of 3.125, 6.25, and 12.5 mg strengths were produced using these blends. Physicochemical properties of the tablets were analyzed using various techniques. X-ray micro-CT was employed to examine tablet porosity and internal structure. The dissolution rate and total drug release were measured to evaluate performance. The study focused on how formulation and laser settings affect final product quality.

The study found that laser intensity significantly influenced tablet hardness and friability. Higher laser intensities led to reduced tablet porosity, as shown by X-ray micro-CT analysis. Carvedilol was present in an amorphous state within the tablets. The dissolution rate of carvedilol varied with laser intensity settings. Tablets with higher laser intensity showed slower drug release rates. The total amount of drug released was also affected by laser parameters. Formulation ratios of carvedilol and Kollidon VA64 impacted tablet properties. The results demonstrated that SLS can be used to produce personalized tablets meeting quality standards.

The study concluded that selective laser sintering is a viable method for manufacturing personalized carvedilol tablets. The laser intensity parameter played a crucial role in determining tablet properties. Adjusting laser settings allowed for control over drug release and tablet strength. The amorphous state of carvedilol in the tablets suggests potential for improved solubility. X-ray micro-CT confirmed that laser intensity affects tablet porosity. The findings support the use of SLS in pharmaceutical applications requiring customization. The study demonstrated that the method can meet patient-specific needs. These results suggest that SLS could be used for other personalized drug formulations.